A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials.

Kathleen Ruchalski,Marta Braschi-Amirfarzan,Michael Douek,Victor Sai,Antonio Gutierrez,Rohit Dewan,Jonathan G. Goldin

A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials.

2021

Kathleen Ruchalski
Marta Braschi-Amirfarzan
Michael Douek
Victor Sai
Antonio Gutierrez
Rohit Dewan
Jonathan G. Goldin

Oncologic imaging in clinical drug trials provides acceptable markers of future response to treatment, which allows shortening the clinical trial length compared with use of standard measures of su...

Keywords:

Clinical trial
primer
Internal medicine
Oncology
drug trial
Medicine
response to treatment
tumor response

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations